March 29, 2012 — Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic valve implantation (TAVI), suggesting that patients with these conditions merit closer evaluation and follow-up, according to research presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Session.

March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a low rate of stent thrombosis, cardiac death, target vessel heart attack and target lesion revascularization years, according to research presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Session.

March 29, 2012 — Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in a specific group of patients, but also increased the risk of severe bleeding, including intracranial bleeding. This was according to research in the TRA 2°P-TIMI 50 Trial presented during the American College of Cardiology (ACC) 61st Annual Scientific Session in Chicago.

March 29, 2012 — A three-pronged intervention in Brazilian public hospitals significantly improved physician adherence to evidence-based protocols for treating acute coronary syndrome (ACS), according to data from the BRIDGE-ACS trial. The research was presented during the American College of Cardiology’s (ACC) 61st Annual Scientific Session this week in Chicago.

March 29, 2012 — VectraCor Inc. announced at the American College of Cardiology’s 61st Annual Scientific Session (ACC) in Chicago that it received U.S. Food and Drug Administration (FDA) approval for the VectraplexECG System with VectraplexAMI. It is a stand-alone cardiac monitor/electrocardiography (ECG) machine with a cardiac electric biomarker (CEB) for real-time detection of ECG changes that may be indicative of an acute myocardial infarction (AMI) plus the capability to derive a 15-lead ECG.

The GE Healthcare ValveAssist software enables trans-aortic valve replacement (TAVR) procedural planning and guidance with integration on live fluoro imaging.
Siemens' syngo Aortic ValveGuide software enables TAVR procedural planning and delivery guidance.
The Siemens syngo Aortic ValveGuide software, similar to other TAVI systems, offers a circle at the base of the valve to indicate when the aortic root is in plain on angiographic imaging. When the circle disappears into a single straight line, the valve is in plain.
Terumo's Onset Solopath introducer sheath in its folded insertion configuration (11 French) and fully-expanded (20.5 French). for the delivery of large percutaneous valves and endovascular aortic stent grafts.
GE Healthcare's Discovery IGS 730 angiography system was recently cleared by the FDA. It uses a wireless, wheeled, laser-guided gantry that offers the benefits of a fixed floor- or ceiling-mounted system, but the mobility of a mobile C-arm.
The EMS Telemed electrocardiogram (ECG) mitt allows fast 12-lead ECG lead placement by anyone, even patients with very little training.
The Hershey's Chocolate booth at ACC was among the most popular. The company handed out free chocolate and copies of clinical studies about the its heart-healthy properi
Hershey's Chocolate booth at ACC.
The Corindus CorPath robotic navigation system, which helps guide cath lab procedures without the need for operators to wear lead aprons, was a centerpiece technology in a hybrid OR display created by Philips Healthcare.
Siemen's AcuNav V intra-cardiac echo catheter.

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A couple of key trends were evident on the show floor – new technology to support trans-aortic valve replacement (TAVR) and the launch of new cardiovascular image and information systems (CVIS) to support healthcare’s proposed Stage 2 meaningful use (MU) requirements.

March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire. FFR measurement identifies the severity of narrowings in the coronary arteries and allows for a more effective assessment of coronary lesions, or blockages, resulting in more accurate diagnosis and improved appropriate treatment of coronary artery blockages.

March 29, 2012 — Siemens Healthcare recently expanded its solutions portfolio by offering the RaySafe i2 personal dosimetry system as an accessory for all Siemens Artis zee angiography systems. By using RaySafe i2 during imaging procedures, medical personnel obtain real-time information regarding their levels of radiation exposure, enabling them to take immediate steps to minimize exposure and establish a high-functioning radiation safety culture within their hospital.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now